Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib

Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib

Zhuo Chen, Zhengkui Jiang, Wenzhou Zhang, Baoxia He The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou 450008, People’s Republic of China Background: The application of the oral targeted therapeutic agent sorafenib provides new hope for patients sufferi...

Full description

Bibliographic Details
Main Authors: Chen Z, Jiang ZK, Zhang WZ, He BX
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Cancer Management and Research
Subjects:
Hepatocellular carcinoma
CPNE3
Copine-III
Molecular targeted agent
Sorafenib-resistance
Online Access:https://www.dovepress.com/silencing--the-expression-of-copine-iii-enhances-the-sensitivity-of-he-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/silencing--the-expression-of-copine-iii-enhances-the-sensitivity-of-he-peer-reviewed-article-CMAR

Similar Items